BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home
»
Newsletters
» BioWorld
BioWorld
March 4, 2002
View Archived Issues
Essential Acquiring Maret For 2M Shares Of Locked-Up Stock
Essential Therapeutics Inc. on Friday said it will strengthen its clinical and preclinical pipeline through the acquisition of Maret Pharmaceuticals Inc. in a deal valued at up to about $6.8 million. (BioWorld Today)
Read More
Titan Cancer Antibodies Paired In Colorectal Phase II Study
Read More
KO Mice Answer In Affirmative; Ablation Of Muc2 Gene Results In Full-Blown Colorectal Cancers
Read More
Peregrine, Oxigene End Venture On Vascular Targeting Agents
Read More
InterMune Goes To Shelf, Files To Sell 2.5M Shares
Read More
Other News To Note
Read More
